Sign in

Jeff Baker

President, Distribution at MYERS INDUSTRIES
Executive

About Jeff Baker

Jeff Baker is President, Distribution at Myers Industries; he was appointed from Vice President, Shared Services on October 1, 2024 and is one of the company’s named executive officers for 2024 . Company performance during his recent tenure included full-year 2024 net sales of $836.3M vs. $813.1M in 2023, adjusted EBITDA of $122.2M vs. $98.0M, and adjusted EPS of $1.04 vs. $1.39; GAAP diluted EPS was $0.19 and free cash flow $54.9M . Myers’ pay-for-performance framework links annual bonuses to Adjusted EBITDA and long-term PSUs to three‑year cumulative adjusted EPS with a relative TSR modifier, aligning management incentives to shareholder value creation .

Past Roles

OrganizationRoleYearsStrategic impact
Myers IndustriesVice President, Shared ServicesThrough Oct 1, 2024Internal operations leadership; elevated to President, Distribution

External Roles

No external directorships or outside roles for Jeff Baker were disclosed in the proxy .

Fixed Compensation

MetricFY 2022FY 2023FY 2024
Salary (paid, $)355,462 380,606 394,903
Base salary rate ($)397,127; +3.0% YoY
Target bonus (%)75% of base
Actual bonus paid ($)342,738 219,136 0 (below threshold)
All other compensation ($)28,533 33,434 45,729

Performance Compensation

Annual Incentive – 2024

MetricWeightingTargetActualPayoutVesting
Adjusted EBITDA100% of annual cash bonusCompany target $149.6M; JB target award $297,845 (75% of base) $122.4M (pre‑incentive expense at threshold) 0% of target; $0 paid Cash (no vesting)

Long-Term Incentives – Design and 2024 Grants

AwardWeightingMetricGrant detailsVesting
Performance Stock Units (PSUs) 2024–202660%3-year cumulative adjusted EPS; rTSR modifier (+/‑25% vs S&P 600 Materials/Industrials percentiles) Target 12,308 PSUs; grant conditioned and issued May 9, 2024; grant date FV $201,482 Vests at end of performance period; settlement Mar 16, 2027
Restricted Stock Units (RSUs) 202440%Service-based8,206 RSUs granted Mar 7, 2024; grant date FV $165,351 Ratable over 3 years on Mar 16, 2024/2025/2026

Completed Performance Cycle – 2022–2024 PSUs

CycleMetricTargetrTSR percentilePayout (pre/post TSR)Result for JB
2022–20243-year cumulative adjusted EBITDA with rTSR modifier $313.0M (50%) / $343.0M (100%) / $403.0M (200%) 16.1% 76.2% → 57.2% after −25% modifier 57.2% of his 9,218 target PSUs

Equity Ownership & Alignment

ItemDetail
Beneficial ownership28,575 shares as of Mar 6, 2025; ~0.08% of 37,295,964 shares outstanding (calculated); underlying figures: ownership and shares outstanding
Unvested RSUs2,048 (2022 grant; final vest Mar 16, 2025) ; 4,957 (2023 grant; vest Mar 16, 2025) ; 8,206 (2024 grant; vest Mar 16, 2024/2025/2026)
Unvested PSUs (target)9,218 (2022–2024) ; 11,154 (2023–2025) ; 12,308 (2024–2026)
OptionsNone disclosed outstanding or vested for NEOs at 12/31/2024
Ownership guidelinePresidents of business units: 1× base salary; compliance required within 5 years
Compliance statusIn compliance as of Dec 31, 2024
Hedging/pledgingProhibited for directors, officers, and employees
Deferred compensationExecutive contributions $179,258; Registrant contributions $10,762; Earnings $101,592; Balance $833,472 (2024)

Upcoming Vesting and Potential Selling Pressure

DateInstrumentAmount
Mar 16, 2025RSUs (2022, 2023, 2024 grants)2,048 (2022 final), 4,957 (2023), plus 2024 tranche (ratable schedule)
Mar 16, 2026RSUs (2024 grant)Remaining tranche (ratable schedule)
Mar 16, 2027PSUs (2024–2026)Settle based on adjusted EPS and rTSR outcomes

Employment Terms

TriggerCash severanceBonus treatmentEquity treatmentBenefitsNotes
Termination without cause or for good reason1× current annual base salary (lump sum) Unvested RSUs forfeited; PSUs fully vest subject to actual performance Health/LTD/life/outplacement for 1 year Company has no individual executive employment contracts
Change-in-control + qualifying termination (double trigger)1.5× (base salary + target bonus) (lump sum) Pro‑rata current year target bonus RSUs fully vest; PSUs vest at target Health 18 months; LTD/life 2 years; outplacement 1 year Double-trigger vesting practice
Death/DisabilityAccrued salary/bonus Pro‑rata target RSUs fully vest; PSUs vest pro‑rata at target Per plan terms
Retirement (eligibility)Not eligible as of 12/31/2024
ClawbackNYSE-compliant policy for erroneously awarded incentive comp on restatement
Tax gross‑upsNone for change‑in‑control payments
Anti‑hedging/pledgingProhibited

Estimated Potential Payments (illustrative as of 12/31/2024)

ScenarioTotal ($)
Termination without cause/for good reason839,893
Death1,136,350
Disability754,498
CIC + qualifying termination1,982,299

Investment Implications

  • Pay-for-performance discipline is evident: 2024 bonuses paid at 0% despite Adjusted EBITDA at threshold, reinforcing variable pay sensitivity to financial outcomes . Long-term PSUs pivoted to adjusted EPS with an rTSR modifier, strengthening linkage to shareholder returns; the prior 2022–2024 cycle settled at 57.2% after underperforming peers (16.1% rTSR percentile) .
  • Alignment and retention: Baker is in compliance with stock ownership guidelines and holds meaningful unvested RSUs/PSUs with near-term vesting events (Mar 16, 2025) and multi‑year PSU exposure (settling Mar 16, 2027), which should mitigate near-term selling pressure but creates scheduled delivery that could add liquidity around vest dates .
  • Downside and change‑in‑control economics: Severance is moderate (1× base), while CIC protection is more substantial (1.5× base+target bonus with full RSU and target PSU vesting), implying low baseline retention risk but meaningful incentives to remain through a transaction scenario .
  • Governance quality: No executive employment contracts, no hedging/pledging, clawback policy, and no tax gross‑ups indicate shareholder‑friendly practices; say‑on‑pay support was 99% in 2024, reducing governance overhang risk .